However, many individuals continue to experience residual cravings, emotional dysregulation, and relapse despite these interventions
Combining GLP-1 analogues with other weight loss medications may enhance results, and researchers continue to study their long-term efficacy and sustainability
The STEP and SURMOUNT trials demonstrated that steady, gradual weight loss continues over the course of treatment, with the most significant results achieved after consistent use for six months to a year
Anti-inflammatory effects of GLP-1-based therapies beyond glucose control
Among them, 19% of the participants had microalbuminuria, and 7% had macroalbuminuria
The researchers note that pricing structures may play a role, as lower doses are sometimes offered at reduced prices through self-pay channels